Drying device for pidotimod bulk pharmaceutical chemicals

Abstract

The invention provides a drying device for pidotimod bulk pharmaceutical chemicals. The drying device comprises a hot cylinder drying assembly and a hot air drying assembly which are arranged up and down; the hot cylinder drying assembly comprises a drying tank, a drying cylinder is arranged in the inner cavity of the drying tank, a heat turning and shoveling assembly is further arranged in the middle of the drying tank, and the heat turning and shoveling assembly comprises a heating rod and a heat conduction rotating sleeve; and the hot air drying assembly comprises a cover body, a filter screen plate is arranged in the cover body, and hot air blowers are arranged below the filter screen plate. The drying device has the advantages that the drying cylinder can be used for heating and drying the bulk pharmaceutical chemicals, heat conduction shovel plates in the heat turning and shoveling assembly can stir-fry the bulk pharmaceutical chemicals continuously, so that the bulk pharmaceutical chemicals are scattered, then the bulk pharmaceutical chemicals can fully perform heat exchange with the drying cylinder, moreover, the heating rod in the heat turning and shoveling assembly is used for enabling the heat conduction shovel plates to heat and dry the bulk pharmaceutical chemicals while the heat conduction shovel plates turn and shovel the heat conduction shovel plates through heat conduction, and then the heating and drying efficiency can be effectively improved; and the hot air drying assembly is adopted, so that hot air is continuously blown into the inner cavity of the drying tank from the bottom of the drying tank, and further heating and drying the heat conduction shovel plates in the drying cylinder are achieved.

Description

technical field [0001] The invention relates to the technical field of drying, in particular to a drying device for pidotimod bulk medicine. Background technique [0002] Pidotimod (PIDOTIMOD) is an immunomodulator, suitable for patients with low immune function, and can be used to prevent acute infection, shorten the course of the disease, reduce the severity of the disease, and can be used as an adjuvant drug during the acute infection period. The main ingredients and chemical names of this product are: Pidotimod (PIDOTIMOD) 400mg (3-L-pyroglutamic acid tetrahydrothiazoline carboxylic acid). At present, drying equipment is inseparable from the processing and production of pidotimod API, but the drying efficiency of the current drying equipment is low, and the drying quality is difficult to guarantee. Contents of the invention [0003] In order to solve the above problems, the invention discloses a drying device for pidotimod bulk drug, which effectively improves the dry...

AI Technical Summary

Problems solved by technology

At present, when processing and producing pidotimod raw materials, drying equipment is indispensable, and the drying efficiency of the current drying equipment is low, and the drying quality is difficult to guarantee

Images